Data Bridge Market Research analyses that the contraceptive devices market was valued at USD 9023.02 million in 2021 and is further estimated to reach USD 14933.06 million by 2029, and is expected to grow at a CAGR of 6.50% during the forecast period of 2022 to 2029.
Contraceptives Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $43,812 million by 2022, registering a CAGR of 6.4% during the period 2016-2022. Contraceptive drugs are expected to dominate the market throughout the study period. North America would continue its lead, accounting for more than one-third share of the world contraceptive market in 2015. Get PDF Sample: https://www.alliedmarketresearch.com/request-sample/451
Data Bridge Market Research analyses that the contraceptive devices market was valued at USD 9023.02 million in 2021 and is further estimated to reach USD 14933.06 million by 2029, and is expected to grow at a CAGR of 6.50% during the forecast period of 2022 to 2029
TBRC global women’s health devices market report includes surgical, diagnostics, contraceptives, labor and delivery, critical care, devices, consumables
The global women’s health market is expected to reach USD 24.48 Billion by 2027, according to a new report by Emergen Research. The women’s healthcare market is experiencing high demand attributable to a growing demand for devices (intrauterine devices, vaginal rings, and implants) and drugs (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) in applications comprising contraceptives, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others.
Analyze Future: Global Medical Devices Market 2014-2018 To Get More Details at: http://www.analyzefuture.com/global-medical-devices-2014-2018-market Medical devices include a broad range of medical instruments used for patient monitoring, and the diagnosis and treatment of a disease or abnormal physical condition, including cardiac, orthopedic, respiratory, and ophthalmic diseases. They range from simple medical devices to complex programmable devices such as pacemakers and laser surgical devices. They are classified based on their characteristics, complexity, and potential harm. TechNavio's analysts forecast the Global Medical Devices market to grow at a CAGR of 4.46 percent over the period 2014-2018.
The global implantable drug delivery devices market is expected to grow from $18.821 billion in 2020 to $20.137 billion in 2021 at a compound annual growth rate (CAGR) of 7%.
The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. Browse full report @ http://goo.gl/StCEXP
Big Market Research has announced a new Report Package "North American Intrauterine Contraceptive Devices (IUCD) Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/north-american-intrauterine-contraceptive-2019-market The North America intrauterine contraceptive devices market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing expenses related to abortion, funds/grants for IUCD products, and technological advancements Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/280196
According to the latest research report by IMARC Group, The global intrauterine devices market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.75% during 2023-2028. More Info:- https://www.imarcgroup.com/intrauterine-devices-market
TBRC global women’s health devices market report includes surgical, diagnostics, contraceptives, labor and delivery, critical care, devices, consumables
The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to latest analysis by Emergen Research. Injectable drug delivery market revenue growth is owing to a rising trend of pre-filled syringes along with technological developments.
The gynecology devices market is projected to reach US$ 25,131.22 million by 2028 from US$ 13,658.41 million in 2022; itis expected to grow at a CAGR of 10.7% from 2022 to 2028.
Implantable Drug Delivery Devices Market, reports on various segments by type, geography, growth, and competitive landscape - says TBRC. http://bit.ly/2IXQldX
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies. For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Major Players in the Implantable Drug Delivery Devices Market are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation Read More @ https://bit.ly/3giwxwe
The North American Intrauterine Contraceptive Devices Market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of this market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception, fewer side effects of IUCDs, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed at reducing abortion-related expenses
Some of the market players featured in the report are Pfizer Inc., Medtronic Inc., Merck & Co., Inc., Bayer AG, Johnson & Johnson, Abbott, SurModics Inc., AstraZeneca Plc., Boston Scientific Corporation
The rising incidences of colorectal cancer, chronic pain, cardiovascular diseases and diabetic retinopathy and unwanted pregnancies globally are expected to drive the implantable drug delivery devices market.
Contraceptive Devices Market demand rising in the upcoming years, Contraceptive devices for female are available in different types that are expected to lead
The global Implantable Drug Delivery Devices Market Report provides a complete analysis of the present situation and potential growth of the global Implantable Drug Delivery Devices Market. This research report provides investors as well as companies that belong to the sector about market trends, drivers of growth, challenges, and opportunities. The purpose of this research is to offer readers valuable data they can use to assist with investment decisions in the Implantable Drug Delivery Devices Market.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Intrauterine Contraceptive Devices for these regions, from 2012 to 2022
The report titled Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory) provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers and restraints.
Data Bridge Market Research analyses the market to grow at a CAGR of 8.1% in the above-mentioned forecast period. https://www.databridgemarketresearch.com/reports/global-implantable-drug-delivery-market
Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section.
Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section.
Healthcare infrastructure – The section provides data on the current health and hygiene status of the citizens based parameters such as: sanitation and safe drinking water access, HIV/AIDS prevalence, contraceptive usage, maternal and infant mortality, hospital bed and physician density etc.
DEVELOPMENT IN INTRAUTERINE DEVICES ( IUD ) Presented BY : AHMAD NOOR, PHARM.D AHMED ALTAYAR, PHARM.D Lecture outlines : What is the IUD ?how does it work ?
Men are motivated by desire to share family planning responsibility & have ... 200 men have been treated with RISUG ... TU 97.7% effective in Chinese men ...
In this market research report, the global hyperspectral imaging technologies market has been broadly classified on the basis of applications For more details : http://goo.gl/pb0hfp
The North American cleansing solutions market research was valued at $69 million in 2013 and is expected to reach $76 million by 2018, at a CAGR of 2.0% during the forecast period, 2013 to 2018. The report also provides an extensive competitive landscaping of the leading companies operating in this market. See Full Report : http://bit.ly/1RaQx63
In addition, surgical or medical procedures are required ... Medical Instruments. Medical instruments are tools designed for precision work (e.g. surgical and ...
In this report, the Global “Prepacked Chromatography Columns market” is broadly classified on the basis of product types and it includes 1-100 ml, 100-1000 ml, and 1L. For more details : http://goo.gl/Zxv2bS
China's demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow and long-term forecasts through 2017 and 2022 are presented.
Oral contraceptives are highly preferable as a first-line treatment for patients without contraindications, on grounds of their efficacy in preventing recurrence of pelvic pain and endometriosis lesions. However, they are associated with possible side effects such as mood changes, nausea, and elevated blood pressure levels. Progestins, on the other hand, require to be consumed periodically, unlike oral contraceptives, which require regular consumption.
According to #TechSci Research report, Saudi Arabia In-Vitro Fertilization (IVF) Market the rising awareness of the adoption of In-Vitro Fertilization treatment as a fertility option is the significant factors contributing to propel the market growth till 2026. Gain More Insight: https://bit.ly/37SRvQI Get Sample Report: https://bit.ly/3zcLKcs Press Release: https://bit.ly/3s8qC6H Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Women’s Health is a branch of medicine that focuses on the prevention and diagnosis of diseases that have an impact on a woman's physical and emotional well-being.
Comprehensive Drug Abuse Prevention ... Clinical Trials Special Treatment Status Permission given to ... federal definition of the role of the pharmacy ...
Preparing for an IDE Application John McLane, Ph.D. COO & Vice President Clinical and Regulatory Affairs Clinquest, Inc. jmclane@clinquest.com IDE Preparation Do your ...
PREVALENCE, AVAILABILITY AND ACCESSABILITY ... 1909 Dr. Richard Richter (Germany): dried silkworm gut. 1923 Dr. Karl Pust (Germany): similar device with tail ...
A combination of expertise falls under the umbrella of ... Hormones and Urology: Male hormone therapy. Erectile dysfunction. Uterine fibroids (Low dose) HRT ...
BIRTH CONTROL AND ABORTION IN AMERICAN HISTORY Jonathon Erlen Let me begin today by stating what I do not intend to deal with, namely the ethical and moral aspects of ...
... trials of quacks caught butchering patients seeking abortions. ... She then married a young architect, William Sanger, and the couple had 3 children. ...
Let me begin today by stating what I do not intend to deal with, namely the ... about birth control 3. omitted any criticisms of lay-run birth control clinics, ...